Clinical Trial Update: Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness [Phase 4]

View source ↗

Summary

This document reports results from a Phase 4 study of subcutaneous methylnaltrexone for opioid-induced constipation in patients with advanced illness, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Opioid-Induced Constipation | Phase 4 | Status: COMPLETED | Results posted: 2018-03-08